Adaptation mechanisms in cancer: Lipid metabolism under hypoxia and nutrient deprivation as a target for novel therapeutic strategies (Review)

Hanahan D: Hallmarks of cancer: New dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI

Pavlova NN, Zhu J and Thompson CB: The hall marks of cancer metabolism: Still emerging. Cell Metab. 34:355–377. 2022. View Article : Google Scholar : PubMed/NCBI

Li F and Simon MC: Cancer Cells don't live alone: Metabolic communication within tumor microenvironments. Dev Cell. 54:183–195. 2020. View Article : Google Scholar : PubMed/NCBI

Koizume S and Miyagi Y: Lipid droplets: A key cellular organelle associated with cancer cell survival under normoxia and hypoxia. Int. J Mol Sci. 17:14302016. View Article : Google Scholar

Broadfield LA, Pane AA, Talebi A, Swinnen JV and Fendt SM: Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell. 56:1363–1393. 2021. View Article : Google Scholar : PubMed/NCBI

Riscal R, Skuli N and Simon MC: Even cancer cells watch their cholesterol! Mol Cell. 76:220–231. 2019. View Article : Google Scholar : PubMed/NCBI

Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L, Lv G, Zong Q, Wang L, Wu Z, et al: Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Sci Adv. 9:eadi24652023. View Article : Google Scholar : PubMed/NCBI

Vanauberg D, Schulz C and Lefebvre T: Involvement of the pro-oncogenic enzyme fatty avid synthase in the hallmarks of cancer: A promising target in anti-cancer therapies. Oncogenesis. 12:162023. View Article : Google Scholar : PubMed/NCBI

Freitas FP, Alborzinia H, dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, Inague A, Klein C, Aroua N, Kaushal K, et al: 7-dehydrocholesterol is endogenous suppressor of ferroptosis. Nature. 626:401–410. 2024. View Article : Google Scholar : PubMed/NCBI

Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L, Wang C, Zhu Z, Chen X, Weng L, et al: 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 626:411–418. 2024. View Article : Google Scholar : PubMed/NCBI

Denko NC: Hypoxia, HIF1 and glucose metabolism in the solid tumor. Nat Rev Cancer. 8:705–713. 2008. View Article : Google Scholar : PubMed/NCBI

Macklin PS, Yamamoto A, Browning L, Hofer M, Adam J and Pugh CW: Recent advances in the biology of tumor hypoxia with relevance to diagnostic practice and tissue-based research. J Pathol. 250:593–611. 2020. View Article : Google Scholar : PubMed/NCBI

Haga N, Saito S, Tsukumo Y, Sakurai J, Furuno A, Tsuruo T and Tomida A: Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions. Cancer Sci. 101:1125–1132. 2010. View Article : Google Scholar : PubMed/NCBI

Kwon SJ and Lee YJ: Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1a in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin. Cancer Res. 11:4694–4700. 2005.

Kikuchi D, Tanimoto K and Nakayama K: CREB is activated by ER stress and modulates the unfolded protein response by regulating the expression of IRE1α and PERK. Biochem. Biophys. Res Commun. 469:243–250. 2016.PubMed/NCBI

Wang HF, Wang ZQ, Ding Y, Piao MH, Feng CS, Chi GF, Luo YN and Ge PF: Endoplasmic reticulum stress regulates oxygen-glucose deprivation-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS. CNS Neurosci Ther. 24:29–38. 2018. View Article : Google Scholar : PubMed/NCBI

Natsuizaka M, Ozasa M, Darmanin S, Miyamoto M, Kondo S, Kamada S, Shindoh M, Higashino F, Suhara W, Koide H, et al: Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res. 313:3337–3348. 2007. View Article : Google Scholar : PubMed/NCBI

Keith B, Johnson RS and Simon MC: HIF1α and HIF2α: Sibling rivalry in hypoxic tumor growth and progression. Nat Rev Cancer. 12:9–22. 2012. View Article : Google Scholar

Wouters BG and Koritzinsky M: Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 8:851–864. 2008. View Article : Google Scholar : PubMed/NCBI

Lee P, Chandel N and Simon MC: Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 21:268–283. 2020. View Article : Google Scholar : PubMed/NCBI

Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, et al: Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am J Pathol. 175:400–411. 2009. View Article : Google Scholar : PubMed/NCBI

Liu W, Glunde K, Bhujwalla ZM, Raman V, Sharma A and Phang JM: Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res. 72:3677–3686. 2012. View Article : Google Scholar : PubMed/NCBI

Chen X, Ilipoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, et al: XBP1 promotes triple-negative breast cancer by controlling the HIF1a pathway. Nature. 508:103–107. 2014. View Article : Google Scholar : PubMed/NCBI

Huang C, Li Y, Li Z, Xu Y, Li N, Ge Y, Dong J, Chang A, Zhao T, Wang X, et al: LIMS1 promotes pancreatic cancer cell survival under oxygen-glucose deprivation conditions by enhancing HIF1A protein translation. Clin Cancer Res. 25:4091–4103. 2019. View Article : Google Scholar : PubMed/NCBI

Saggese P, Pandey A, Alcaraz M, Fung E, Hall A, Yanagawa J, Rodriguez EF, Grogan TR, Giurato G, Nassa G, et al: Glucose deprivation promotes pseudohypoxia and de-differentiation in lung adenocarcinoma. Cancer Res. 84:305–327. 2024. View Article : Google Scholar : PubMed/NCBI

Zhao T, Jiang T, Li X, Chang S, Sun Q, Kong F, Kong X, Wei F, He J, Hao J, et al: Nuclear GRP78 promotes metabolic reprogramming and therapeutic resistance in pancreatic ductal adenocarcinoma. Clin Cancer Res. 29:5183–5195. 2023. View Article : Google Scholar : PubMed/NCBI

Nishimoto A, Kugiyama N, Hosoyama T, Enoki T, Li TS and Hamano K: HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells. Int J Oncol. 44:2077–2084. 2014. View Article : Google Scholar : PubMed/NCBI

Takai M, Takauchi M, Kuribayashi M and Tsujiuchi T: LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions. Biochem Biophys Res Commun. 661:21–27. 2023. View Article : Google Scholar : PubMed/NCBI

Davern M, Fitzgerald MC, Buckley CE, Heeran AB, Donlon NE, McGrath J, O'Connel F, Deshpande MR, Hayes C, MacDonald J, et al: PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumors. Transl Oncol. 19:1013812022. View Article : Google Scholar : PubMed/NCBI

Buzzai M, Bauer DE, Jones RG, DeBerardinis RJ, Hatzivassiliou G, Elstrom RL and Tompson CB: The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation. Oncogene. 24:4165–4173. 2005. View Article : Google Scholar : PubMed/NCBI

Leithner K, Triebl A, Trotzmuller M, Hinteregger B, Leko P, Wieser BI, Grasmann G, Bertsch AL, Züllig T, Stacher E, et al: The glycerol backbone of phospholipids derives from noncarbohydrate precursors in staved lung cancer cells. Proc Natl Acad Sci USA. 115:6225–6230. 2018. View Article : Google Scholar : PubMed/NCBI

Cai M, He J, Xiong J, Tay LWR, Wang Z, Rog C, Wang J, Xie Y, Wang G, Banno Y, et al: Phospholipase D1-regulated autophagy supplies free fatty acids to counter nutrient stress in cancer cells. Cell Death Dis. 7:e24482016. View Article : Google Scholar : PubMed/NCBI

Khan AUH, Salehi H, Alexia C, Valdivielso JM, Bozic M, Lopez-Mejia IC, Fajas L, Gerbal-Chaloin S, DaujatChavanieu M, Gitenay D, et al: Glucose starvation or pyruvate dehydrogenase activation induce a broad, ERK5-mediated, metabolic remodeling leading to fatty acid oxidation. Cells. 11:13922022. View Article : Google Scholar : PubMed/NCBI

Hoang-Minh LB, Siebzehnrubl FA, Yang C, Suzuki-Hatano S, Dajac K, Loche T, Andrews N, Massari MS, Patel J, Amin K, et al: Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma. EMBO J. 37:e987722018. View Article : Google Scholar : PubMed/NCBI

Wang C, Haas MA, Yeo SK, Paul R, Yang F, Vallabhapurapu S, Qi X, Plas DR and Guan JL: Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis. Br J Cancer. 124:1711–1723. 2021. View Article : Google Scholar : PubMed/NCBI

Liu R, Lee JH, Li J, Yu R, Tan L, Xia Y, Zheng Y, Bian XL, Lorenzi PL, Chen Q, et al: Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. Mol Cell. 81:2722–2735. 2021. View Article : Google Scholar : PubMed/NCBI

Chauhan SS, Casillas AL, Vizzerra AD, Liou H, Clements AN, Flores CE, Prevost CT, Kashatus DF, Snider AJ, Snider JM, et al: PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer. Oncogene. 43:406–419. 2024. View Article : Google Scholar : PubMed/NCBI

Cao B, Deng H, Cui H, Zhao R, Li H, Wei B and Chen L: Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation. Cancer Cell Int. 21:4812021. View Article : Google Scholar : PubMed/NCBI

Monteiro-Cardoso VF, Silva AM, Oliveira MM, Peixoto F and Videira RA: Membrane lipid profile alterations are associated with the metabolic adaptation of the Caco-2 cells to a glycemic nutritional condition. J Bioenerg Biomembr. 46:45–57. 2014. View Article : Google Scholar : PubMed/NCBI

Spencer AG, Woods JW, Arakawa T, Singer II and Smith WI: Subcellular localization of prostaglandin endoperoxide H synthase-1 and −2 by immunoelectron microscopy. J Biol Chem. 273:9886–9893. 1998. View Article : Google Scholar : PubMed/NCBI

Roberts HR, Smartt HJM, Greenhough A, Moore AE, Williams AC and Paraskeva C: Colon tumor cells increase PGE2 by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Carcinogenesis. 32:1741–1747. 2011. View Article : Google Scholar : PubMed/NCBI

Hwang SH, Yang Y, Jung JH and Kim Y: Oleic acid from cancer-associated fibroblast promotes cancer cell stemness by stearoyl-CoA desaturase under glucose-deficient condition. Cancer Cell Int. 22:4042022. View Article : Google Scholar : PubMed/NCBI

Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, Heiden MGV, Miller G, Drebin JA, Bar-Sagi D, et al: Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75:544–553. 2015. View Article : Google Scholar : PubMed/NCBI

Gameiro PA, Yang J, Metelo AM, Perez-Carro R, Baker R, Wang Z, Arreola A, Rathmell WK, Olumi A, López-Larrubia P, et al: In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab. 17:372–385. 2013. View Article : Google Scholar : PubMed/NCBI

Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R, White EP, Thompson CB and Rabinowitz JD: Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci USA. 110:8882–8887. 2013. View Article : Google Scholar : PubMed/NCBI

Miess H, Dankworth B, Gouw AM, Rosenfeldt M, Schmitz W, Jiang M, Saunders B, Howell M, Downward J, Felsher DW, et al: The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene. 37:5435–5450. 2018. View Article : Google Scholar : PubMed/NCBI

Byun JK, Choi YK, Kim JH, Jeong JY, Jeon HJ, Kim MK, Hwang I, Lee SY, Lee YM, Lee IK, et al: A positive feedback loop between Sestrin 2 and mTORC2 is required for the survival of glutamine-depleted lung cancer cells. Cell Rep. 20:586–599. 2017. View Article : Google Scholar : PubMed/NCBI

Babbar M, Huang Y, An J, Landas SK and Sheikh MS: CHTM1, a novel metabolic marker deregulated in human malignancies. Oncogene. 37:2052–2066. 2018. View Article : Google Scholar : PubMed/NCBI

Juh JW, Yan JB, Lin ZH, Lin SC and Peng IC: SREBP1-induced glutamine synthetase triggers a feedforward loop to upregulate SREBP1 through Sp1 O-GlcNAcylation and augments lipid droplet formation in cancer cells. Int J Mol Sci. 22:98142021. View Article : Google Scholar

Zhu R, Yang Y, Shao F, Wang J, Gao Y, He J and Lu Z: Choline kinase alpha2 promotes lipid droplet lipolysis in non-small-cell lung carcinoma. Front Oncol. 22:8484832022. View Article : Google Scholar : PubMed/NCBI

Guo X, Wang A, Wang W, Wang Y, Chen H, Liu X, Xia T, Zhang A, Chen D, Qi H, et al: HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple negative breast cancer. Mol Oncol. 15:642–656. 2021. View Article : Google Scholar : PubMed/NCBI

De Santis MC, Gozzelino L, Margaria JP, Costamagna A, Ratto E, Gulluni F, Gregorio ED, Mina E, Lorito N, Bacci M, et al: Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. Gut. 72:360–371. 2023. View Article : Google Scholar : PubMed/NCBI

Kong Y, Wu M, Wan X, Sun M, Zhang Y, Wu Z, Li C, Liang X, Gao L, Ma C, et al: Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. Redox Biol. 63:1027322023. View Article : Google Scholar : PubMed/NCBI

Nedara K, Reinhardt C, Lebraud E, Arena G, Gracia C, Buard V, Pioche-Durieu C, Castelli F, Colsch B, Bénit P, et al: Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine depletion. Front Oncol. 12:9581552022. View Article : Google Scholar : PubMed/NCBI

Lorenz NI, Sittig ACM, Urban H, Luger AL, Engel AL, Munch C, Steinbach JP and Ronellenfitsch MW: Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide. Sci Rep. 11:141612021. View Article : Google Scholar : PubMed/NCBI

Pan M, Reid MA, Lowman XH, Kulkarni RP, Tran TQ, Liu X, Yang Y, Hernandez-Davies JE, Rosales KK, Li H, et al: Regional glutamine deficiency in tumors promotes dedifferentiation through inhibition of histone demethylation. Nat Cell Biol. 18:1090–1101. 2016. View Article : Google Scholar : PubMed/NCBI

Jain M, Nilsson R, Sharma S, Madhusudhan N, Kiytami T, Souza AL, Kafri R, Kirschner MW, Clish CB and Mootha VK: Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 336:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI

Gao X, Lee K, Reid MA, Sanderson SM, Qiu C, Li S, Liu J and Locasale JW: Serine availability influences mitochondrial dynamics and function through lipid metabolism. Cell Rep. 22:3507–3520. 2018. View Article : Google Scholar : PubMed/NCBI

Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E and Vousden KH: Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 493:542–546. 2013. View Article : Google Scholar : PubMed/NCBI

Muthusamy T, Cordes T, Handzlik MK, You L, Lim EW, Gengatharan J, Pinto AFM, Badur MG, Kolar MJ, Wallace M, et al: Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature. 586:790–795. 2020. View Article : Google Scholar : PubMed/NCBI

Truman JP, Ruiz CF, Montal E, Garcia-Barros M, Mileva I, Snider AJ, Hannun YA, Obeid LM and Mao C: 1-Deoxysphinganine initiates adaptive responses to serine and glycine starvation in cancer cells via proteolysis of sphingosine kinase. J Lipid Res. 63:1001542022. View Article : Google Scholar : PubMed/NCBI

Yun HJ, Li M, Guo D, Jeon SM, Park SH, Lim JS, Lee SB, Liu R, Du L, Kim SH, et al: AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. J Exp Clin Cancer Res. 42:3402023. View Article : Google Scholar : PubMed/NCBI

Bonifacio VDB, Pereira SA, Serpa J and Vicente JB: Cysteine metabolic circuitries: Druggable targets in cancer. Br J Cancer. 124:862–879. 2021. View Article : Google Scholar : PubMed/NCBI

Cunningham A, Oudejans LL, Geugien M, Pereira-Martins DA, Wierenga ATJ, Erdem A, Sternadt D, Huls G and Schuringa JJ: The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia. Blood Adv. 8:56–69. 2024. View Article : Google Scholar : PubMed/NCBI

Upadhyayula PS, Higgins DM, Mela A, Banu M, Dovas A, Zandkarimi F, Patel P, Mahajan A, Humala N, Nguyen TTT, et al: Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism. Nature Commun. 14:11872023. View Article : Google Scholar : PubMed/NCBI

Kerimoglu B, Lamb C, McPherson RD, Ergen E, Stone EM and Ooi A: Cysteinase-rapamycin combination induces ferroptosis in both in vitro and in vivo models of hereditary leiomyomatosis and renal cell carcinoma. Mol Caner Ther. 21:419–426. 2022. View Article : Google Scholar

Liu N, Lin X and Huang C: Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance. Br J Cancer. 122:279–92. 2020. View Article : Google Scholar : PubMed/NCBI

Armenta DA, Laqtom NN, Alchemy G, Dong W, Morrow D, Poltorack CD, Nathanson DA, Abu-Remaileh M and Dixon S: Ferroptosis inhibition by lysosome-dependent catabolism of extracellular protein. Cell Chem Biol. 29:1588–1600. 2022. View Article : Google Scholar : PubMed/NCBI

Chen PH, Wu J, Ding CKC, Lin CC, Pan S, Bossa N, Xu Y, Yang WH, Mathey-Prevot B and Chi JT: Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death Differ. 27:1008–1022. 2020. View Article : Google Scholar : PubMed/NCBI

Li Y, Wang X, Huang Z, Zhou Y, Xia J, Hu W, Wang X, Du J, Tong X and Wang Y: CISD3 inhibition drives cysteine-deprivation induced ferroptosis. Cell Death Dis. 12:8392021. View Article : Google Scholar : PubMed/NCBI

Liu D, Liang C, Huang B, Zhuang X, Cui W, Yang L, Yang Y, Zhang Y, Fu X, Zhang X, et al: Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth. Adv Sci. 10:22040062023. View Article : Google Scholar

Hong SE, Kim MR, Jang SK, Seong MK, Kim HA, Noh WC, Jin HO and Park IC: Hypoxia suppresses cysteine deprivation-induced cell death via ATF4 regulation in MDA-MB-231 breast cancer cells. Anticancer Res. 40:1387–1394. 2020. View Article : Google Scholar : PubMed/NCBI

Qiu F, Chen YR, Liu X, Chu CY, Shen LJ, Xu J, Gaur S, Forman HJ, Zhang H, Zheng S, et al: Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells. Sci Signal. 7:ra312014. View Article : Google Scholar : PubMed/NCBI

Hu Q, Dai J, Zhang Z, Yu H, Zhang J, Zhu X, Qin Y, Zhang L and Zhang P: ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer Res. 83:1646–1665. 2023. View Article : Google Scholar : PubMed/NCBI

Brashears CB, Barlin M, Ehrhardt WR, Rathore R, Schultze M, Tzeng SC, Tine BAV and Held JM: Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming. Cell Death Dis. 11:6622020. View Article : Google Scholar : PubMed/NCBI

Long Y, Tsai WB, Wangpaichitr M, Tsukamoto T, Savaraj N, Feun LG and Kuo MT: Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction. Mol Cancer Ther. 12:2581–2590. 2013. View Article : Google Scholar : PubMed/NCBI

Burrows N, Cane G, Robson M, Gaude E, Howat WJ, Szlosarek PW, Pedley RB, Frezza C, Ashcroft M and Maxwell PH: Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20). Sci Rep. 6:229502016. View Article : Google Scholar : PubMed/NCBI

Guenin S, Morvan D, Thivat E, Stepien G and Demidem A: Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming. Nutr Cancer. 61:518–529. 2009. View Article : Google Scholar : PubMed/NCBI

Harada S, Taketomi Y, Aiba T, Kawaguchi M, Hirabayashi T, Uranbileg B, Kurano M, Yatomi Y and Murakami M: The lisophospholipase PNPLA7 controls hepatic choline and methionine metabolism. Biomolecules. 13:4172023. View Article : Google Scholar

Yokogami K, Kikuchi T, Watanabe T, Nakatake Y, Yamashita S, Mizuguchi A and Takeshima H: Methionine regulates self-renewal pluripotency, and cell death of GIC through cholesterol-rRNA axis. BMC Cancer. 22:13512022. View Article : Google Scholar : PubMed/NCBI

Young RM, Ackerman D, Quinn ZL, Mancuso A, Gruber M, Liu L, Giannoukos DN, Bobrovnikova-Marjon E, Diehl JA, Keith B, et al: Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. Genes Dev. 27:1115–1131. 2013. View Article : Google Scholar : PubMed/NCBI

Li Z, Ji BW, Dixit PD, Tchourine K, Lien EC, Hosios AM, Abbott KL, Rutter JC, Westermark AM, Gorodetsky EF, et al: Cancer cells depend on environmental lipids for proliferation when electron acceptors are limited. Nat Metab. 4:711–723. 2022. View Article : Google Scholar : PubMed/NCBI

Qiu B, Ackermann D, Sanchez DJ, Li B, Ochocki JD, Grazioli A, Bobrovnikova-Marjon E, Diehl A, Keith B and Simon C: HIF2α-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 5:652–667. 2015. View Article : Google Scholar : PubMed/NCBI

Du W, Zhang L, Brett-Morris A, Aguila B, Kerner J, Hoppel CL, Puchowicz M, Serra D, Herrero L, Rini BI, et al: HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Nat Commun. 8:17692017. View Article : Google Scholar : PubMed/NCBI

Chen C, Zhao W, Lu X, Ma Y, Zhang P, Wang Z, Cui Z and Xia Q: AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma. Cancer Sci. 113:2600–2615. 2022. View Article : Google Scholar : PubMed/NCBI

Brezis M and Rosen S: Hypoxia of the renal medulla-Its implications for disease. N Eng J Med. 332:647–655. 1995. View Article : Google Scholar : PubMed/NCBI

Little RA, Jamin Y, Boult JKR, Naish JH, Watson Y, Cheung S, Holliday KF, Lu H, McHugh DJ, Irlam J, et al: Mapping hypoxia in renal carcinoma with oxygen-enhanced MRI. Radiology. 288:739–747. 2018. View Article : Google Scholar : PubMed/NCBI

Ackerman D, Tumanov S, Qiu B, Michalopoulou E, Spata M, Azzam A, Xie H, Simon MC and Kamphorst JJ: Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 24:2596–2605. 2018. View Article : Google Scholar : PubMed/NCBI

Ji JX, Wang YK, Cochrane DR and Huntsman DG: Clear cell carcinomas of the ovary and kidney: Clarity through genomics. J Pathol. 244:550–564. 2018. View Article : Google Scholar : PubMed/NCBI

Lee S, Garner EIO, Welch WR, Berkowitz RS and Mok SC: Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 106:311–317. 2007. View Article : Google Scholar : PubMed/NCBI

Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, Power J, Coward J, Cowin PA, House CM, et al: IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell carcinoma. Clin Cancer Res. 17:2538–2548. 2011. View Article : Google Scholar : PubMed/NCBI

Spowart JE, Townsend KN, Huwait H, Eshragh S, West NR, Ries JN, Kalloger S, Anglesio M, Gorski SM, Watson PH, et al: The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol. 228:437–447. 2012. View Article : Google Scholar : PubMed/NCBI

Koizume S, Ito S, Miyagi E, Hirahara F, Nakamura Y, Sakuma Y, Osaka H, Takano Y, Ruf W and Miyagi Y: HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic condition in ovarian cancer cells. Nucleic Acid Res. 40:5389–5401. 2012. View Article : Google Scholar : PubMed/NCBI

Koizume S and Miyagi Y: Tissue factor in cancer-associated thromboembolism: Possible mechanisms and clinical applications. Br J Cancer. 127:2099–2107. 2022. View Article : Google Scholar : PubMed/NCBI

Koizume S, Ito S, Nakamura Y, Yoshihara M, Furuya M, Yamada R, Miyagi E, Hirahara F, Takano Y and Miyagi Y: Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Mol Cancer. 14:772015. View Article : Google Scholar : PubMed/NCBI

Koizume S, Kanayama T, Kimura Y, Hirano H, Takahashi T, Ota Y, Miyazaki K, Yoshihara M, Nakamura Y, Yokose T, et al: Cancer cell-derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin. Cancer Sci. 114:2485–2498. 2023. View Article : Google Scholar : PubMed/NCBI

Trigatti BL and Gerber GE: A direct role for serum albumin in the cellular uptake of long-chain fatty acids. Biochem. J. 308:155–159. 1995.PubMed/NCBI

Koizume S, Takahashi T, Nakamura Y, Yoshihara M, Ota Y, Sato S, Tadokoro H, Yokose T, Kato H, Miyagi E, et al: Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma. Br J Cancer. 127:462–473. 2022. View Article : Google Scholar : PubMed/NCBI

Koizume S, Takahashi T, Yoshihara M, Nakamura Y, Ruf W, Takenaka K, Miyagi E and Miyagi Y: Cholesterol starvation and hypoxia activate the FVII gene via the SREBP1-GILZ pathway in ovarian cancer cells to produce procoagulant microvesicles. Thromb Haemost. 119:1058–1071. 2019. View Article : Google Scholar : PubMed/NCBI

Lewis CA, Peck B, Bensaad K, Griffiths B, Mitter R, Chakravarty P, East P, Dankworth B, Alibhai D, Harris AL and Schulze A: SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme. Oncogene. 34:5128–5140. 2015. View Article : Google Scholar : PubMed/NCBI

Schug ZT, Peck B, Jones DT, Zhang Q, Grosskurth S, Alam IS, Goodwin LM, Smethurst E, Mason S, Blyth K, et al: Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 27:57–71. 2015. View Article : Google Scholar : PubMed/NCBI